ReviewPatient preference and adherence2023

Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability.

Joanna Narbutt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.